Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,450.00    -105.00 (-1.60%)
Bid:
6,470.00
Ask:
5,970.00
Spread: -500.00 (-7.728%)
Market Cap: £4.84b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Board Appointment

22 Oct 2025 07:00

RNS Number : 2860E
Spirax Group PLC
22 October 2025
 

 

22 October 2025

Board Appointment

 

Spirax Group plc, the leading global thermal energy management and fluid technology solutions Group, is pleased to announce the appointment of Andrew Kemp as an Independent Non-Executive Board Director and member of the Audit Committee with effect from 1 November 2025.

 

Andrew is Chair of the Audit Committee Chairs' Independent Forum and is a Non-Executive Director and Audit Committee Chair at both The Berkeley Group Holdings plc and Irwin Mitchell Holdings Limited. In addition, Andrew is a Governor of Birkbeck University of London where he chairs the Finance Committee and he was previously a Non-Executive Director of SCS Group plc. Prior to that, Andrew spent almost 39 years serving PwC's FTSE100 clients in the UK and internationally.

 

On 1 April 2026, Andrew will succeed Kevin Thompson as Chair of the Audit Committee and Kevin will step down from the Board at the Company's Annual General Meeting (AGM) in May 2026. Until then, Kevin and Andrew will work together to manage a smooth handover.

 

Tim Cobbold, Chair, commented: "I am delighted to welcome Andrew to Spirax Group. He brings deep expertise to the Board and the Audit Committee, along with significant experience as a Non-Executive Director and Audit Committee Chair of both large listed and privately held companies.

 

"On behalf of the Board, I would like to express our thanks to Kevin for his significant contribution to Spirax Group. Kevin's extensive experience and commitment have been instrumental in guiding Spirax Group through some important milestones as the business has grown and developed. When Kevin steps down at the AGM next year to spend more time with family and friends, he will leave with our utmost appreciation and good wishes for the future."

 

Andrew Kemp's appointment is part of the succession planning undertaken by the Nomination Committee to recruit Non-Executive Directors with the skills and experience required to support the implementation of the Group's Together for Growth Strategy.

 

There are no further disclosures to be made pursuant to UKLR 6.4.6R and 6.4.8R.

 

For further information:

Celine Barroche, General Counsel and Company Secretary

+44 (0) 1242 535 276

 

Media

Martin Robinson, Teneo:

+44 (0) 20 7260 2700

 

spiraxgroup@teneo.com

 

 

About Spirax Group

Spirax Group is positioned to play a critical role in enabling the industrial transition to net zero, aligned to our Purpose to create sustainable value for all our stakeholders as we engineer a more efficient, safer and sustainable world. We put solving customers' problems at the heart of our 'total solutions' approach. Our global thermal energy and fluid technology solutions improve operating efficiency and safety in our customers' critical industrial processes. Our decarbonisation solutions use proprietary technologies to eliminate scope 1 and 2 greenhouse gas emissions* by electrifying boilers for the raising of steam, as well as the electrification of other critical industrial process heating applications.

Spirax Group comprises three strong and aligned Businesses: Steam Thermal Solutions helps customers control and manage steam within their mission critical industrial applications, such as cleaning, sterilising, cooking and heating. We are helping to put food safely on the world's tables and keeping our hospitals running. Electric Thermal Solutions has proprietary technologies that deliver electrification solutions at scale in industrial settings, including for the raising of steam, supporting our customers to achieve their net zero goals. We also deliver freeze protection and defrost solutions critical to aviation and space industries and ensure thermal uniformity in Semiconductor chip manufacturing to power the critical electronic systems we rely on. Watson‐Marlow Fluid Technology Solutions is optimising the efficient use of resources and supporting advancements in global health, such as lifesaving vaccines and gene therapies.

Spirax Group is headquartered in Cheltenham (UK). We have 37 strategically located manufacturing plants around the world and are committed to creating a safe and inclusive working culture for our 10,000 colleagues, operating in 66 countries and serving 110,000 customers globally. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and we are a constituent of the FTSE 100 and the FTSE4Good Indexes.

*When connected to a green electricity source.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFIDIALLFIE
Date   Source Headline
25th Jun 20143:05 pmRNSHolding(s) in Company
23rd Jun 20148:49 amRNSHolding(s) in Company
12th Jun 20148:10 amRNSHolding(s) in Company
11th Jun 20144:08 pmRNSHolding(s) in Company
6th Jun 20145:41 pmRNSDirector/PDMR Shareholding
5th Jun 20144:31 pmRNSDirector/PDMR Shareholding
5th Jun 20144:04 pmRNSTotal Voting Rights
29th May 20143:43 pmRNSDirector/PDMR Shareholding
23rd May 20144:29 pmRNSDirector/PDMR Shareholding
21st May 20144:29 pmRNSHolding(s) in Company
20th May 20145:50 pmRNSResult of AGM
20th May 20147:00 amRNSInterim Management Statement
7th May 20144:18 pmRNSTotal Voting Rights
30th Apr 20144:59 pmRNSDirector/PDMR Shareholding
17th Apr 20143:40 pmRNSDirector/PDMR Shareholding
8th Apr 20144:25 pmRNSDirector/PDMR Shareholding
2nd Apr 201411:12 amRNSHolding(s) in Company
24th Mar 20144:28 pmRNSAnnual Financial Report
24th Mar 201410:35 amRNSDirector/PDMR Shareholding
11th Mar 20148:30 amRNSDirectorate Change
6th Mar 20147:00 amRNSFinal Results
25th Feb 20147:30 amRNSChange of Director Details
22nd Jan 201411:04 amRNSNotification of Key Dates
6th Jan 20148:36 amRNSAcquisition
3rd Jan 20144:33 pmRNSTotal Voting Rights
16th Dec 20134:10 pmRNSHolding(s) in Company
16th Dec 20139:30 amRNSChange of Auditor
16th Dec 20138:30 amRNSBoard Succession Changes
11th Dec 20132:59 pmRNSDirector/PDMR Shareholding
10th Dec 20139:00 amRNSDirector Declaration
5th Dec 20134:27 pmRNSTotal Voting Rights
29th Nov 20134:21 pmRNSHolding(s) in Company
27th Nov 20134:20 pmRNSDirector/PDMR Shareholding
18th Nov 201312:36 pmRNSDirector/PDMR Shareholding
14th Nov 20134:28 pmRNSDirector/PDMR Shareholding
7th Nov 20137:00 amRNSInterim Management Statement
5th Nov 20134:24 pmRNSTotal Voting Rights
11th Oct 20139:08 amRNSDirector/PDMR Shareholding
2nd Oct 20132:00 pmRNSTotal Voting Rights
2nd Oct 20139:48 amRNSNotification of Release Date - IMS
23rd Sep 20138:41 amRNSHolding(s) in Company
3rd Sep 20138:56 amRNSTotal Voting Rights
30th Aug 20138:00 amRNSAcquisition
22nd Aug 20133:56 pmRNSHolding(s) in Company
13th Aug 20134:28 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNS2013 Half Year Results
7th Aug 201310:00 amRNSBoard Changes
6th Aug 20134:26 pmRNSTotal Voting Rights
12th Jul 20133:20 pmRNSDates for 2013 Half-Year Results
5th Jul 20135:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.